A survival analysis of psychostimulant prescriptions in New South Wales from 1990 to 2010

Matthew C. Lambert, Robert Reid, Brenton Prosser, Regina Bussing

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Objective: Psychostimulant medication is considered a mainstay in the treatment of attention-deficit/hyperactivity disorder (ADHD); however, research suggests that the typical duration of medication treatment for children and youth may be <3 years. The purpose of this study was to evaluate the psychostimulant treatment persistence for children and adolescents in New South Wales, Australia. Methods: This study used survival analysis to assess duration of medication treatment on a large administrative database of children and youth from New South Wales, Australia. Several models were fit to evaluate differences in survival rates among decades (1990-1999 vs. 2000-2010), gender, and age. Results: Results showed that: 1) Overall median treatment time (i.e., median survival time) was 1.96 years (99% CI=1.93, 1.99); 2) there were small, but significant changes over time in duration of treatment; 3) females had shorter treatment duration than males; and 4) there were relatively large differences in treatment duration across age groups. Conclusions: These results indicate that the majority of children and youth receive medication treatment for only a small portion of childhood/adolescence, and that there are differential patterns in treatment duration across age groups.

Original languageEnglish (US)
Pages (from-to)475-481
Number of pages7
JournalJournal of Child and Adolescent Psychopharmacology
Volume25
Issue number6
DOIs
StatePublished - Aug 1 2015

Fingerprint

New South Wales
Survival Analysis
Prescriptions
Therapeutics
South Australia
Age Groups
Attention Deficit Disorder with Hyperactivity
Survival Rate
Databases

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

A survival analysis of psychostimulant prescriptions in New South Wales from 1990 to 2010. / Lambert, Matthew C.; Reid, Robert; Prosser, Brenton; Bussing, Regina.

In: Journal of Child and Adolescent Psychopharmacology, Vol. 25, No. 6, 01.08.2015, p. 475-481.

Research output: Contribution to journalReview article

@article{c4c1080a8db047ab8db0747a96782dc9,
title = "A survival analysis of psychostimulant prescriptions in New South Wales from 1990 to 2010",
abstract = "Objective: Psychostimulant medication is considered a mainstay in the treatment of attention-deficit/hyperactivity disorder (ADHD); however, research suggests that the typical duration of medication treatment for children and youth may be <3 years. The purpose of this study was to evaluate the psychostimulant treatment persistence for children and adolescents in New South Wales, Australia. Methods: This study used survival analysis to assess duration of medication treatment on a large administrative database of children and youth from New South Wales, Australia. Several models were fit to evaluate differences in survival rates among decades (1990-1999 vs. 2000-2010), gender, and age. Results: Results showed that: 1) Overall median treatment time (i.e., median survival time) was 1.96 years (99{\%} CI=1.93, 1.99); 2) there were small, but significant changes over time in duration of treatment; 3) females had shorter treatment duration than males; and 4) there were relatively large differences in treatment duration across age groups. Conclusions: These results indicate that the majority of children and youth receive medication treatment for only a small portion of childhood/adolescence, and that there are differential patterns in treatment duration across age groups.",
author = "Lambert, {Matthew C.} and Robert Reid and Brenton Prosser and Regina Bussing",
year = "2015",
month = "8",
day = "1",
doi = "10.1089/cap.2014.0151",
language = "English (US)",
volume = "25",
pages = "475--481",
journal = "Journal of Child and Adolescent Psychopharmacology",
issn = "1044-5463",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - A survival analysis of psychostimulant prescriptions in New South Wales from 1990 to 2010

AU - Lambert, Matthew C.

AU - Reid, Robert

AU - Prosser, Brenton

AU - Bussing, Regina

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Objective: Psychostimulant medication is considered a mainstay in the treatment of attention-deficit/hyperactivity disorder (ADHD); however, research suggests that the typical duration of medication treatment for children and youth may be <3 years. The purpose of this study was to evaluate the psychostimulant treatment persistence for children and adolescents in New South Wales, Australia. Methods: This study used survival analysis to assess duration of medication treatment on a large administrative database of children and youth from New South Wales, Australia. Several models were fit to evaluate differences in survival rates among decades (1990-1999 vs. 2000-2010), gender, and age. Results: Results showed that: 1) Overall median treatment time (i.e., median survival time) was 1.96 years (99% CI=1.93, 1.99); 2) there were small, but significant changes over time in duration of treatment; 3) females had shorter treatment duration than males; and 4) there were relatively large differences in treatment duration across age groups. Conclusions: These results indicate that the majority of children and youth receive medication treatment for only a small portion of childhood/adolescence, and that there are differential patterns in treatment duration across age groups.

AB - Objective: Psychostimulant medication is considered a mainstay in the treatment of attention-deficit/hyperactivity disorder (ADHD); however, research suggests that the typical duration of medication treatment for children and youth may be <3 years. The purpose of this study was to evaluate the psychostimulant treatment persistence for children and adolescents in New South Wales, Australia. Methods: This study used survival analysis to assess duration of medication treatment on a large administrative database of children and youth from New South Wales, Australia. Several models were fit to evaluate differences in survival rates among decades (1990-1999 vs. 2000-2010), gender, and age. Results: Results showed that: 1) Overall median treatment time (i.e., median survival time) was 1.96 years (99% CI=1.93, 1.99); 2) there were small, but significant changes over time in duration of treatment; 3) females had shorter treatment duration than males; and 4) there were relatively large differences in treatment duration across age groups. Conclusions: These results indicate that the majority of children and youth receive medication treatment for only a small portion of childhood/adolescence, and that there are differential patterns in treatment duration across age groups.

UR - http://www.scopus.com/inward/record.url?scp=84939177295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939177295&partnerID=8YFLogxK

U2 - 10.1089/cap.2014.0151

DO - 10.1089/cap.2014.0151

M3 - Review article

C2 - 26218772

AN - SCOPUS:84939177295

VL - 25

SP - 475

EP - 481

JO - Journal of Child and Adolescent Psychopharmacology

JF - Journal of Child and Adolescent Psychopharmacology

SN - 1044-5463

IS - 6

ER -